Literature DB >> 25584219

Comparison of various methods used to detect biofilm production of Candida species.

Rahul P Dhale1, M V Ghorpade2, C A Dharmadhikari3.   

Abstract

PURPOSE: The biofilm of organisms can be considered as a virulence factor because of the resistance towards antimicrobial agents. Formation of Candida biofilms are observed in blood, mucosal surface and most medical devices i.e. nonliving objects in patient's body. The study was undertaken to conclude the most sensitive and specific test for detection of biofilm formation.
MATERIALS AND METHODS: Quantitative measurement of biofilm formation was assessed by three methods- 1) XTT reductionassay, 2) Percentage Transmission (%T) and 3) Crystal Violet assay in microtitre plate for 425 Candida isolates.
RESULTS: Out of 425 Candida strains, XTT reduction assay gave 72 Biofilm positive strains accounting for 16.94 %. The percentage transmission (% T) method gave 56 strains Biofilm positive (13.17 %) and Crystal violet assay gave 50 positive strains (11.76 %). Compared to Percentage Transmission (% T) and Crystal violet method, XTT reduction assay gave maximum percentage of Biofilm positivity.
CONCLUSION: In comparison of 3 methods used for detection of biofilm formation, XTT reduction assay was the most sensitive and specific method.

Entities:  

Keywords:  Biofilm; XTT reduction assay

Year:  2014        PMID: 25584219      PMCID: PMC4290237          DOI: 10.7860/JCDR/2014/10445.5147

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  11 in total

1.  Biofilm production by clinical isolates of Candida species.

Authors:  C P Girish Kumar; Thangam Menon
Journal:  Med Mycol       Date:  2006-02       Impact factor: 4.076

2.  Comparative analysis of Candida biofilm quantitation assays.

Authors:  Heather T Taff; Jeniel E Nett; David R Andes
Journal:  Med Mycol       Date:  2011-05-04       Impact factor: 4.076

3.  Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources.

Authors:  Jong Hee Shin; Seung Jung Kee; Myung Geun Shin; Soo Hyun Kim; Dong Hyeon Shin; Sang Ku Lee; Soon Pal Suh; Dong Wook Ryang
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

4.  Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.

Authors:  Mohammed A Al-Fattani; L Julia Douglas
Journal:  J Med Microbiol       Date:  2006-08       Impact factor: 2.472

5.  Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection.

Authors:  Y Jin; H K Yip; Y H Samaranayake; J Y Yau; L P Samaranayake
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Improvement of XTT assay performance for studies involving Candida albicans biofilms.

Authors:  Wander José da Silva; Jayampath Seneviratne; Nipuna Parahitiyawa; Edvaldo Antonio Ribeiro Rosa; Lakshman Perera Samaranayake; Altair Antoninha Del Bel Cury
Journal:  Braz Dent J       Date:  2008

7.  Biofilm formation by Candida albicans isolated from intrauterine devices.

Authors:  Priyanka Lal; Vishnu Agarwal; Parul Pruthi; Ben M J Pereira; M R Kural; Vikas Pruthi
Journal:  Indian J Microbiol       Date:  2009-01-08       Impact factor: 2.461

8.  Characterization of biofilm formed on intrauterine devices.

Authors:  V Pruthi; A Al-Janabi; B M J Pereira
Journal:  Indian J Med Microbiol       Date:  2003 Jul-Sep       Impact factor: 0.985

9.  Identification, typing, antifungal resistance profile, and biofilm formation of Candida albicans isolates from Lebanese hospital patients.

Authors:  Ibrahim Bitar; Roy A Khalaf; Houda Harastani; Sima Tokajian
Journal:  Biomed Res Int       Date:  2014-06-01       Impact factor: 3.411

10.  Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.

Authors:  Leighann Sherry; Ranjith Rajendran; David F Lappin; Elisa Borghi; Federica Perdoni; Monica Falleni; Delfina Tosi; Karen Smith; Craig Williams; Brian Jones; Chris J Nile; Gordon Ramage
Journal:  BMC Microbiol       Date:  2014-07-05       Impact factor: 3.605

View more
  7 in total

1.  Antifungal activity of magnoflorine against Candida strains.

Authors:  Jaegoo Kim; Thinh Ha Quang Bao; Yu-Kyong Shin; Ki-Young Kim
Journal:  World J Microbiol Biotechnol       Date:  2018-10-31       Impact factor: 3.312

Review 2.  Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action.

Authors:  Ranita Roy; Monalisa Tiwari; Gianfranco Donelli; Vishvanath Tiwari
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

Review 3.  Helicobacter pylori Biofilm-Related Drug Resistance and New Developments in Its Anti-Biofilm Agents.

Authors:  Chong Hou; Fangxu Yin; Song Wang; Ailing Zhao; Yingzi Li; Yipin Liu
Journal:  Infect Drug Resist       Date:  2022-04-05       Impact factor: 4.003

4.  Biofilm formation and its effect on the management of culture-positive bacterial endophthalmitis.

Authors:  Dimple Lodha; Roshni Karolia; Savitri Sharma; Joveeta Joseph; Taraprasad Das; Vivek P Dave
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

5.  Evaluation of the biofilm life cycle between Candida albicans and Candida tropicalis.

Authors:  María Belén Atiencia-Carrera; Fausto Sebastián Cabezas-Mera; Karla Vizuete; Alexis Debut; Eduardo Tejera; António Machado
Journal:  Front Cell Infect Microbiol       Date:  2022-08-18       Impact factor: 6.073

6.  Biofilm-Forming Potential of Ocular Fluid Staphylococcus aureus and Staphylococcus epidermidis on Ex Vivo Human Corneas from Attachment to Dispersal Phase.

Authors:  Ranjith Konduri; Chinthala Reddy Saiabhilash; Sisinthy Shivaji
Journal:  Microorganisms       Date:  2021-05-22

7.  The Candida albicans TOR-Activating GTPases Gtr1 and Rhb1 Coregulate Starvation Responses and Biofilm Formation.

Authors:  Peter R Flanagan; Ning-Ning Liu; Darren J Fitzpatrick; Karsten Hokamp; Julia R Köhler; Gary P Moran
Journal:  mSphere       Date:  2017-11-15       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.